Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, July 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
JBS Publication Demonstrates Utility of InSphero 3D Co-Culture Microtissues as Phenotypic RNAi Screening Tool
Friday, March 21, 2014
Report in the Journal of Biomolecular Screening establishes fluorescent 3D tumor co-culture model, enables screening of gene function in a system more reflective of in vivo tumor growth.

New Series of Eppendorf Serological Pipets
Wednesday, March 19, 2014
Provide optimal levels of quality for cell culture.

New Centrifuge Delivers High-Performance, High-Volume Batch Bioprocessing
Wednesday, March 19, 2014
Ready-to-run system combines powerful centrifuge and 10 liter carbon fiber rotor for exceptional productivity in pharmaceutical, biotech and academic communities.

New PrimeSurface™ Culture Ware Now Available from Alpha Laboratories
Saturday, March 15, 2014
Ideal for spheroid cell colony formation.

Xylem Helps to Optimize and Control Bioprocessing and Life Sciences Applications
Wednesday, March 12, 2014
The Company’s YSI brand 2900 Series Biochemistry Analyzers have the ability to accurately and rapidly monitor and control fermentations and cell cultures.

SFU Completes Installation of Electron Microscopes from FEI
Tuesday, March 11, 2014
SFU’s new multi-million-dollar Centre for Soft Materials now offers the most advanced suite of microscopes in Western Canada.

Ultra Low Adhesion Plates for Superior 3D Spheroid Cell Culture
Tuesday, March 04, 2014
Lipidure®-Coat low adhesion plates and dishes from AMSBIO.

Irisbiosciences a New Player in 3D Cell Culture
Friday, February 14, 2014
Irisbiosciences is focused on the development, manufacturing and marketing of products for bio-/pharmaceutical research and development, namely 3D cell culture products, tissue models and human & stem cells for in-vitro experimentation.

New Article by Spinnovation Biologics’ CEO Frederic Girard
Friday, February 07, 2014
New article details NMR for Quality by Design biologics development.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 220
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv